Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ISIS

Ionis Pharmaceuticals, (ISIS)

Ionis Pharmaceuticals,
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ISIS
DateTimeSourceHeadlineSymbolCompany
06/01/201023:00PR Newswire (US)Isis Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare ConferenceNASDAQ:ISIS
06/01/201000:00PR Newswire (US)Excaliard Initiates Phase 2 Trials in U.S. for its Skin Scarring Drug, EXC 001NASDAQ:ISIS
22/12/200900:15PR Newswire (US)Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to TevaNASDAQ:ISIS
24/11/200900:00PR Newswire (US)Isis Pharmaceuticals (Nasdaq: ISIS) Letter to ShareholdersNASDAQ:ISIS
20/10/200922:00PR Newswire (US)Isis Pharmaceuticals to Present at the 4th Annual BIOCOM Investor ConferenceNASDAQ:ISIS
09/09/200921:00PR Newswire (US)Isis Pharmaceuticals to Present at Morgan Stanley's Global Healthcare Unplugged ConferenceNASDAQ:ISIS
06/08/200922:23Dow Jones NewsIsis 2Q Loss Narrows, Helped By Genzyme PartnershipNASDAQ:ISISIsis Pharmaceuticals Inc.
06/08/200921:00PR Newswire (US)Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009NASDAQ:ISIS
04/08/200921:00PR Newswire (US)Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth ConferenceNASDAQ:ISIS
21/05/200903:45Dow Jones NewsUPDATE: Genzyme, Isis Cholesterol Drug Data Raise QuestionsNASDAQ:ISISIsis Pharmaceuticals Inc.
21/05/200900:06Dow Jones NewsGenzyme, Isis Cholesterol Drug Meets Goal In Late StudyNASDAQ:ISISIsis Pharmaceuticals Inc.
07/05/200921:54Dow Jones NewsIsis Swings To 1Q Profit Amid Gain, Partnership RevenueNASDAQ:ISISIsis Pharmaceuticals Inc.
15/02/200600:00PR Newswire (US)OncoGenex Appoints New CFO and Board MemberNASDAQ:ISIS
16/08/200523:18PR Newswire (US)OncoGenex Announces Completion of $12.8 Million Venture FinancingNASDAQ:ISIS
 Showing the most relevant articles for your search:NASDAQ:ISIS